Stayble Therapeutics AB Logo

Stayble Therapeutics AB

STABL | ST

Overview

Corporate Details

ISIN(s):
SE0013513652 (+1 more)
LEI:
549300WD23DE1US21868
Country:
Sweden
Address:
Lennart Torstenssonsgatan 6, 412 56 Göteborg
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Stayble Therapeutics AB develops injectable treatments for chronic back pain. Their solutions target the root cause of disc-related pain.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Stayble Therapeutics AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Stayble Therapeutics AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Stayble Therapeutics AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Curevac Logo Curevac Germany CVAC
Cyclezyme AB Logo Cyclezyme AB Sweden CYCLE
Cyxone AB Logo Cyxone AB Sweden CYXO
DBV Technologies Logo DBV Technologies France DBV
DEINOVE Logo DEINOVE France ALDEI
Deutsche Biotech Innovativ AG Logo Deutsche Biotech Innovativ AG Germany DBI
Devyser Diagnostics Logo Devyser Diagnostics Sweden DVYSR
Diamyd Medical AB (publ) Logo Diamyd Medical AB (publ) Sweden DMYD
Diasorin Logo Diasorin Italy DIA
DNA Group (T.R.) Ltd. Israel DNA